Contents
pdf Download PDF pdf Download XML
469 Views
269 Downloads
Share this article
Research Article | Volume 2 Issue 4 (None, 2008) | Pages 49 - 51
Fixed drug eruption followed by lichen aureus during abatacept add-on therapy of rheumatoid arthritis
 ,
Under a Creative Commons license
Open Access
PMID : PMC3157784
Received
Oct. 30, 2008
Published
Dec. 27, 2008
Abstract

Background:Abatacept is a soluble fusion protein approved as add-on drug in rheumatoid arthritis.Main observations:Here we report the first case of fixed drug eruption followed by lichen aureus due to abatacept in a 67-year-old woman.Conclusion:Fixed drug eruption is an unexpected drug reaction for abatacept, since T-cell activation is inhibited.

Keywords
Recommended Articles
Research Article
Morphological Spectrum of Renal Pathology in Autopsy Kidneys: A Retrospective Cross-sectional Study
Published: 25/03/2025
Research Article
Autoimmune vesiculobullous disorders- a study of clinicohistopathological correlation
Published: 13/07/2026
Research Article
A typical presentation of Tinea Faciei incidence across all the age groups
Published: 13/07/2026
Research Article
Prevalence of Extended-Spectrum Beta-Lactamase Production and Biofilm Formation Among Klebsiella pneumoniae Urinary Isolates
Published: 05/03/2019
© Copyright Spejalisci Dermatolodzy